Cargando…
Quantitative investigation of the affinity of human respiratory syncytial virus phosphoprotein C-terminus binding to nucleocapsid protein
BACKGROUND: There are no approved small molecule drug therapies for human respiratory syncytial virus (hRSV), a cause of morbidity and mortality in at-risk newborns, the immunocompromised, and the elderly. We have investigated as a potential novel hRSV drug target the protein-protein interaction bet...
Autores principales: | Shapiro, Adam B, Gao, Ning, O’Connell, Nichole, Hu, Jun, Thresher, Jason, Gu, Rong-Fang, Overman, Ross, Hardern, Ian M, Sproat, Graham G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239318/ https://www.ncbi.nlm.nih.gov/pubmed/25407889 http://dx.doi.org/10.1186/s12985-014-0191-2 |
Ejemplares similares
-
Structural landscape of the respiratory syncytial virus nucleocapsids
por: Gonnin, Lorène, et al.
Publicado: (2023) -
Amino acid sequence of human respiratory syncytial virus nucleocapsid protein.
por: Elango, N, et al.
Publicado: (1983) -
In vitro trackable assembly of RNA-specific nucleocapsids of the respiratory syncytial virus
por: Gao, Yunrong, et al.
Publicado: (2020) -
Cryo-EM structure of the nucleocapsid-like assembly of respiratory syncytial virus
por: Wang, Yan, et al.
Publicado: (2023) -
Sub-Nucleocapsid Nanoparticles: A Nasal Vaccine against Respiratory Syncytial Virus
por: Roux, Xavier, et al.
Publicado: (2008)